Retina is protected by neuroserpin from ischemic/reperfusion-induced injury independent of tissue-type plasminogen activator

PLoS ONE

Volumn 10, Issue 7, 2015, Pages

  Gu, R P ^a   Fu, L L ^b   Jiang, C H ^a,c   Xu, Y F ^a   Wang, X ^a   Yu, J ^a  

^a FUDAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c Department of Neurology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; NEUROSERPIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; TISSUE PLASMINOGEN ACTIVATOR; NEUROPEPTIDE; SERINE PROTEINASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTRORETINOGRAPHY; INTRAOCULAR PRESSURE; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; REPERFUSION INJURY; RETINA ISCHEMIA; ANIMAL; C57BL MOUSE; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; HUMAN; INJURIES; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RETINA; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 9; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEUROPEPTIDES; NEUROPROTECTION; REPERFUSION INJURY; RETINA; SERPINS; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84941343181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130440     Document Type: Article

References (52)

1. Mitka M (2013) Early treatment of ischemic stroke with intravenous tPA reduces disability risk. JAMA 310: 1111. doi: 10.1001/jama.2013.278292 PMID: 24045728
2. Millard WB (2013) New guidelines on tPA in stroke: putting out fires with gasoline? Ann Emerg Med 62: A13-A18. doi: 10.1016/j.annemergmed.2013.05.010 PMID: 23842066
3. Gonzalez RG, Furie KL, Goldmacher GV, Smith WS, Kamalian S, Payabvash S, et al. (2013) Good outcome rate of 35% in IV-tPA-treated patients with computed tomography angiography confirmed severe anterior circulation occlusive stroke. Stroke 44: 3109-3113. doi: 10.1161/STROKEAHA.113.001938 PMID: 24003051
4. Hattenbach LO, Allers A, Gumbel HO, Scharrer I, Koch FH (1999) Vitreous concentrations of TPA and plasminogen activator inhibitor are associated with VEGF in proliferative diabetic vitreoretinopathy. Retina 19: 383-389. PMID: 10546932
5. Johnson RN, Olsen KR, Hernandez E (1989) Intravitreal tissue plasminogen activator treatment of experimental vitreous hemorrhage. Arch Ophthalmol 107: 891-894. PMID: 2499298
6. Vote BJ, Buttery R, Polkinghorne PJ (2004) Endophthalmitis after intravitreal injection of frozen preprepared tissue plasminogen activator (tPA) for pneumatic displacement of submacular hemorrhage. Retina 24: 808-809. PMID: 15492643
7. Parathath SR, Parathath S, Tsirka SE (2006) Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J Cell Sci 119: 339-349. PMID: 16410551
8. Benchenane K, Castel H, Boulouard M, Bluthe R, Fernandez-Monreal M, Roussel BD, et al. (2007) Anti-NR1 N-terminal-domain vaccination unmasks the crucial action of tPA on NMDA-receptor-mediated toxicity and spatial memory. J Cell Sci 120: 578-585. PMID: 17244650
9. Chen SN, Yang TC, Ho CL, Kuo YH, Yip Y, Chao AN. (2003) Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology 110: 704-708. PMID: 12689889
10. Yamamoto T, Kamei M, Kunavisarut P, Suzuki M, Tano Y (2008) Increased retinal toxicity of intravitreal tissue plasminogen activator in a central retinal vein occlusion model. Graefes Arch Clin Exp Ophthalmol 246: 509-514. PMID: 17960414
11. Krueger SR, Ghisu GP, Cinelli P, Gschwend TP, Osterwalder T, Wolfer DP, et al. (1997) Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse. J Neurosci 17: 8984-8996. PMID: 9364046
12. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, et al. (1997) Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem 272: 33062-33067. PMID: 9407089
13. Osterwalder T, Contartese J, Stoeckli ET, Kuhn TB, Sonderegger P (1996) Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J 15: 2944-2953. PMID: 8670795
14. Sumi Y, Dent MA, Owen DE, Seeley PJ, Morris RJ (1992) The expression of tissue and urokinase-type plasminogen activators in neural development suggests different modes of proteolytic involvement in neuronal growth. Development 116: 625-637. PMID: 1289056
15. Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P, et al. (2002) Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 106: 740-745. PMID: 12163437
16. Yepes M, Sandkvist M, Wong MK, Coleman TA, Smith E, Cohan SL, et al. (2000) Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96: 569-576. PMID: 10887120
17. Cinelli P, Madani R, Tsuzuki N, Vallet P, Arras M, Zhao CN, et al. (2001) Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci 18: 443-457. PMID: 11922137
18. Husain S, Liou GI, Crosson CE (2011) Opioid receptor activation: suppression of ischemia/reperfusioninduced production of TNF-alpha in the retina. Invest Ophthalmol Vis Sci 52: 2577-2583. doi: 10.1167/ iovs.10-5629 PMID: 21282567
19. Shima C, Adachi Y, Minamino K, Okigaki M, Shi M, Imai Y, et al. (2012) Neuroprotective effects of granulocyte colony-stimulating factor on ischemia-reperfusion injury of the retina. Ophthalmic Res 48: 199-207. doi: 10.1159/000340059 PMID: 22868688
20. Chen FT, Yang CM, Yang CH (2013) The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina. PLoS One 8: e64262. doi: 10.1371/journal.pone. 0064262 PMID: 23691186
21. Hughes WF (1991) Quantitation of ischemic damage in the rat retina. Exp Eye Res 53: 573-582. PMID: 1743256
22. Hsiao Y, Zou T, Ling CC, Hu H, Tao XM, Song HY. (2008) Disruption of tissue-type plasminogen activator gene in mice aggravated liver fibrosis. J Gastroenterol Hepatol 23: e258-e264. PMID: 17944888
23. Wu J, Echeverry R, Guzman J, Yepes M (2010) Neuroserpin protects neurons from ischemia-induced plasmin-mediated cell death independently of tissue-type plasminogen activator inhibition. Am J Pathol 177: 2576-2584. doi: 10.2353/ajpath.2010.100466 PMID: 20864675
24. Rodriguez-Gonzalez R, Millan M, Sobrino T, Miranda E, Brea D, de la Ossa NP, et al. (2011) The natural tissue plasminogen activator inhibitor neuroserpin and acute ischaemic stroke outcome. Thromb Haemost 105: 421-429. doi: 10.1160/TH10-09-0621 PMID: 21174006
25. Rodriguez-Gonzalez R, Agulla J, Perez-Mato M, Sobrino T, Castillo J (2011) Neuroprotective effect of neuroserpin in rat primary cortical cultures after oxygen and glucose deprivation and tPA. Neurochem Int 58: 337-343. doi: 10.1016/j.neuint.2010.12.006 PMID: 21163314
26. Huang P, Huo Y, Lou LX, Li H, Barnstable CJ, Zhang C, et al. (2013) CD4 positive T helper cells contribute to retinal ganglion cell death in mouse model of ischemia reperfusion injury. Exp Eye Res 115: 131-139. doi: 10.1016/j.exer.2013.06.015 PMID: 23792169
27. Dent MA, Sumi Y, Morris RJ, Seeley PJ (1993) Urokinase-type plasminogen activator expression by neurons and oligodendrocytes during process outgrowth in developing rat brain. Eur J Neurosci 5: 633-647. PMID: 8261137
28. Nykjaer A, Petersen CM, Moller B, Jensen PH, Moestrup SK, Holtet TL, et al. (1992) Purified alpha 2- macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J Biol Chem 267: 14543-14546. PMID: 1378833
29. Bu G, Maksymovitch EA, Schwartz AL (1993) Receptor-mediated endocytosis of tissue-type plasminogen activator by low density lipoprotein receptor-related protein on human hepatoma HepG2 cells. J Biol Chem 268: 13002-13009. PMID: 8389767
30. Makarova A, Mikhailenko I, Bugge TH, List K, Lawrence DA, Strickland DK (2003) The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes. J Biol Chem 278: 50250-50258. PMID: 14522960
31. Yepes M, Lawrence DA (2004) New functions for an old enzyme: nonhemostatic roles for tissue-type plasminogen activator in the central nervous system. Exp Biol Med (Maywood) 229: 1097-1104.
32. Yepes M, Lawrence DA (2004) Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system? Trends Cardiovasc Med 14: 173-180. PMID: 15261888
33. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112: 1533-1540. PMID: 14617754
34. Yepes M, Sandkvist M, Coleman TA, Moore E, Wu JY, Mitola D, et al. (2002) Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J Clin Invest 109: 1571-1578. PMID: 12070304
35. Gelderblom M, Neumann M, Ludewig P, Bernreuther C, Krasemann S, Arunachalam P, et al. (2013) Deficiency in serine protease inhibitor neuroserpin exacerbates ischemic brain injury by increased postischemic inflammation. PLoS One 8: e63118. doi: 10.1371/journal.pone.0063118 PMID: 23658802
36. Ma J, Yu D, Tong Y, Mao M (2012) Effect of neuroserpin in a neonatal hypoxic-ischemic injury model ex vivo. Biol Res 45: 357-362. doi: 10.4067/S0716-97602012000400005 PMID: 23558991
37. Lee TW, Coates LC, Birch NP (2008) Neuroserpin regulates N-cadherin-mediated cell adhesion independently of its activity as an inhibitor of tissue plasminogen activator. J Neurosci Res 86: 1243-1253. PMID: 18092357
38. Shu Q, Xu Y, Zhuang H, Fan J, Sun Z, Zhang M, et al. (2014) Ras Homolog Enriched in the Brain is Linked to Retinal Ganglion Cell Apoptosis after Light Injury in Rats. J Mol Neurosci.
39. Yang Y, Duan JZ, Gui DM, Yang HW, Gao DW (2011) Effect of aminoguanidine on caspase-3 expression in rat retina after ischemia-reperfusion injury. Int J Ophthalmol 4: 259-261. doi: 10.3980/j.issn. 2222-3959.2011.03.09 PMID: 22553657
40. Kermer P, Ankerhold R, Klocker N, Krajewski S, Reed JC, Bähr M. (2000) Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res 85: 144-150. PMID: 11146116
41. Hanninen VA, Pantcheva MB, Freeman EE, Poulin NR, Grosskreutz CL (2002) Activation of caspase 9 in a rat model of experimental glaucoma. Curr Eye Res 25: 389-395. PMID: 12789547
42. Mohr S, Xi X, Tang J, Kern TS (2002) Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 51: 1172-1179. PMID: 11916941
43. Barber AJ, Nakamura M, Wolpert EB, Reiter CE, Seigel GM, Antonetti DA, et al. (2001) Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Akt-mediated mechanism that reduces the activation of caspase-3. J Biol Chem 276: 32814-32821. PMID: 11443130
44. Wu B, Ootani A, Iwakiri R, Fujise T, Tsunada S, Toda S, et al. (2004) Ischemic preconditioning attenuates ischemia-reperfusion-induced mucosal apoptosis by inhibiting the mitochondria-dependent pathway in rat small intestine. Am J Physiol Gastrointest Liver Physiol 286: G580-G587. PMID: 15010362
45. White BC, Sullivan JM, DeGracia DJ, O'Neil BJ, Neumar RW, Grossman LI, et al. (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179: 1-33. PMID: 11054482
46. Hill RM1, Brennan SO, Birch NP.(2001)Expression, purification, and functional characterization of the serine protease inhibitor neuroserpin expressed in Drosophila S2 cells.Protein Expr Purif. 22(3):406-13. PMID: 11483002
47. Hastings GA1, Coleman TA, Haudenschild CC, Barthlow R, et al.(1997)Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival.J Biol Chem. 26; 272(52):33062-7. PMID: 9407089
48. London A, Benhar I, Schwartz M (2013) The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol 9: 44-53. doi: 10.1038/nrneurol.2012.227 PMID: 23165340
49. D'Onofrio PM, Koeberle PD (2013) What can we learn about stroke from retinal ischemia models? Acta Pharmacol Sin 34: 91-103. doi: 10.1038/aps.2012.165 PMID: 23202803
50. Tian Y, Li B, Shi WZ, Chang MZ, Zhang GJ, Di ZL, et al. (2014) Dynamin-related protein 1 inhibitors protect against ischemic toxicity through attenuating mitochondrial Ca2+ uptake from endoplasmic reticulum store in PC12 cells. Int J Mol Sci 15: 3172-3185. doi: 10.3390/ijms15023172 PMID: 24566142
51. Sun D, Vingrys AJ, Kalloniatis M (2007) Metabolic and functional profiling of the ischemic/reperfused rat retina. J Comp Neurol 505: 114-130. PMID: 17729266
52. Kim YR, Kim HN, Jang JY, Park C, Lee JH, Shin HK, et al. (2013) Effects of electroacupuncture on apoptotic pathways in a rat model of focal cerebral ischemia. Int J Mol Med 32: 1303-1310. doi: 10.3892/ ijmm.2013.1511 PMID: 24085154